One would have thought that the market for sleep aids would struggle in 2022, after two years of double-digit value growth during the COVID-19 crisis. Consumers' stress levels were high during the pandemic, leading to increased anxiety and insomnia. Many people feared losing their jobs and businesses and needed to both work from home and home-school their children during periods of lockdown. As a result, immense pressure was placed on people, and consumers increased the value they placed on slee...
Euromonitor International's Sleep Aids in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Sleep Aids in Belgium
Euromonitor International
September 2022
List Of Contents And Tables
SLEEP AIDS IN BELGIUM
KEY DATA FINDINGS
2022 DEVELOPMENTS
New impetus to sales
Ongoing explosion of innovation and advertising support
Metagenics retains top spot but Lunestil from STADA Arzneimittel AG is a hit
PROSPECTS AND OPPORTUNITIES
Ongoing robust growth expected for sleep aids in the wake of COVID-19 and the context of rising inflation
Possible new competition from Rx products or other consumer health alternatives
Importance of distinctive positioning, and emergence of CBD
CATEGORY DATA
Table 1 Sales of Sleep Aids: Value 2017-2022
Table 2 Sales of Sleep Aids: % Value Growth 2017-2022
Table 3 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 4 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 5 Forecast Sales of Sleep Aids: Value 2022-2027
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
CONSUMER HEALTH IN BELGIUM
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources